Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Public Biopharma Financings Plunge In 2016, But Is It A Sign Of Health?

Jul 26 2016

• By Mandy Jackson

trading

Related Content

Biotech Walloped On Clinton Drug Price Controls Threat

Sep 22 2015

Alder Readies To Take On Teva, Others In Migraine

Mar 30 2016

Deal Watch: Galenica Offers For Relypsa, But Other Suitors May Emerge

Jul 21 2016

Half of 2016 Biotech IPOs Positive At Mid-Year; 2015 Success Rate Sours

Jul 10 2016

Related Companies

Alder Biopharmaceuticals, Inc.

Relypsa, Inc.

Additional Topics

Commercial Business Strategies BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window